Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
Score 1
2008 pubmed 6 citations

Systemic dissemination in cancer of unknown primary is independent of mutational inactivation of the KiSS-1 metastasis-suppressor gene.

Dova. L L; Golfinopoulos. V V; Pentheroudakis. G G; Georgiou. I I; Pavlidis. N N

Key Findings

  • Only 1 out of 50 unknown primary tumors had a point mutation (P81R) in the KiSS1 gene.
  • The other 49 tumors had a normal KiSS1 sequence, identical to healthy people.
  • Systemic dissemination in these cancers is likely driven by genes other than KiSS1 or by epigenetic changes.

Practical Outcomes

  • For biohackers, this study doesn’t provide any new protocols or dosage guidance for kisspeptin-10. It suggests that targeting KiSS1 mutations isn’t a useful strategy for influencing cancer spread, so focus on other pathways or interventions.

Summary

Researchers looked at a gene called KiSS1, which makes the peptide kisspeptin, in 50 cancers where the original tumor site is unknown. They found only one tumor with a tiny mutation in KiSS1, meaning most of these cancers have a normal KiSS1 gene. So, the spread of these cancers isn’t likely caused by changes in KiSS1, but probably by other genetic or epigenetic factors.

Abstract

Cancer of unknown primary represents a heterogeneous group of malignancies characterised by early systemic dissemination and lack of primary site. KiSS1 is a member of the metastasis-suppressor gene family whose functional role is being investigated in human malignancies. We extracted DNA from 50 paraffin-embedded unknown primary tumors and screened KiSS1 exons III and IV for presence of mutations by means of Single Strand Conformational Polymorphism and direct sequencing. Only one tumor specimen harboured a cytosine to guanine point substitution in base 242 of exon IVa, resulting in a proline to arginine switch at codon 81 of the KiSS1 protein (P81R). The remaining 49 tumors harbored wild-type KiSS1 alleles, indistinguishable from those of peripheral blood lymphocytes of 50 healthy controls. Consequently, the propensity for systemic spread of unknown primary tumors may by due to mutations in genes other than KiSS1 or aberrant epigenetic regulation.

Study Information

Provider

pubmed

Year

2008

Date

2008-03-20T00:00:00.000Z

DOI

10.1007/s12253-008-9024-1

Citations

6

References

4